Workflow
恩华药业: 2025年第一次临时股东大会决议公告

Meeting Details - The shareholders' meeting of Jiangsu Enhua Pharmaceutical Co., Ltd. was held on June 13, 2025, at 9:00 AM [1] - The meeting combined on-site voting and online voting, with specific voting times outlined for both methods [1] - The meeting was convened by the board of directors and presided over by Chairman Sun Pengsheng [1] Attendance and Voting - A total of 353 participants attended the meeting, representing 539,930,290 shares, which is 53.1335% of the total voting shares [2] - Among the attendees, 6 participated on-site, representing 487,253,371 shares (47.9497% of total voting shares), while 347 participated via online voting [2] - Small and medium investors accounted for 52,943,719 shares, or 5.2101% of the total voting shares [2] Proposal Voting Results - The meeting approved a proposal regarding the repurchase and cancellation of restricted stock, with all involved parties abstaining from voting [3] - The proposal required a two-thirds majority of the valid voting rights present at the meeting to pass, which was achieved [4] Legal Opinion - The meeting was witnessed by lawyers from Beijing Lifang Law Firm, who confirmed that the convening and voting procedures complied with relevant laws and regulations [4]